Physiology of Penile Erection and Pathophysiology of Erectile Dysfunction

  • Anthony J. Bella
  • William O. Brant
  • Tom F. Lue
Part of the Medical Radiology book series (MEDRAD)

Abstract

Penile erection is primarily a neurovascular event modulated by psychological and hormonal status. Sexual stimulation causes a release of neurotransmitters from the cavernous nerve terminals and relaxing factors from the endothelial cells in the penis, resulting in relaxation of smooth muscle in the arteries and arterioles supplying the erectile tissue.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Angulo J, Cuevas P, Fernandez A et al (2003) Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 312: 1202–1208PubMedCrossRefGoogle Scholar
  2. Angulo J, Cuevas P, Gabancho S et al (2005) Enhancement of both EDHF and NO/cGMP pathways is necessary to reverse erectile dysfunction in diabetic rats. J Sex Med 2: 341–346PubMedCrossRefGoogle Scholar
  3. Araujo AB, Durante R, Feldman HA et al (1998) The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 60: 458–465PubMedGoogle Scholar
  4. Araujo AB, Mohr BA, McKinlay JB (2004) Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc 52: 1502–1509PubMedCrossRefGoogle Scholar
  5. Bancroft J, Wu FC (1983) Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav 12: 59–66PubMedCrossRefGoogle Scholar
  6. Banya Y, Ushiki T, Takagane H et al (1989) Two circulatory routes within the human corpus cavernosum penis: a scanning electron microscopic study of corrosion casts. J Urol 142: 879–883PubMedGoogle Scholar
  7. Braun M, Wassmer G, Klotz T et al (2000) Epidemiology of erectile dysfunction: results of the Cologne Male Survey. Int J Impot Res 12: 305–311PubMedCrossRefGoogle Scholar
  8. Cartledge JJ, Eardley I, Morrison JF (2001) Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes. BJU Int 87: 402–407PubMedCrossRefGoogle Scholar
  9. Chang SW, Fine R, Siegel D et al (1991) The impact of diuretic therapy on reported sexual function. Arch Intern Med 151: 2402–2408PubMedCrossRefGoogle Scholar
  10. Christ GJ, Maayani S, Valcic M et al (1990) Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues. Br J Pharmacol 101: 375–381PubMedGoogle Scholar
  11. Corona G, Mannucci E, Mansani R et al (2004) Aging and pathogenesis of erectile dysfunction. Int J Impot Res 16: 395–402PubMedCrossRefGoogle Scholar
  12. Deutsch S, Sherman L (1980) Previously unrecognized diabetes mellitus in sexually impotent men. JAMA 244: 2430–2432PubMedCrossRefGoogle Scholar
  13. Ehmke H, Junemann KP, Mayer B et al (1995) Nitric oxide synthase and vasoactive intestinal polypeptide colocalization in neurons innervating the human penile circulation. Int J Impot Res 7: 147–156PubMedGoogle Scholar
  14. Faerman I, Glocer L, Fox D et al (1974) Impotence and diabetes. Histological studies of the autonomic nervous fibers of the corpora cavernosa in impotent diabetic males. Diabetes 23: 971–976PubMedGoogle Scholar
  15. Feldman HA, Goldstein I, Hatzichristou DG et al (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151: 54–61PubMedGoogle Scholar
  16. Fournier GR, Jr., Juenemann KP, Lue TF et al (1987) Mechanisms of venous occlusion during canine penile erection: an anatomic demonstration. J Urol 137: 163–167PubMedGoogle Scholar
  17. Grimm RH, Jr., Grandits GA, Prineas RJ et al (1997) Longterm effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 29: 8–14PubMedGoogle Scholar
  18. Herman A, Adar R, Rubinstein Z (1978) Vascular lesions associated with impotence in diabetic and nondiabetic arterial occlusive disease. Diabetes 27: 975–81PubMedCrossRefGoogle Scholar
  19. Horowitz JD, Goble AJ (1979) Drugs and impaired male sexual function. Drugs 18: 206–217PubMedCrossRefGoogle Scholar
  20. Hu JC, Elkin EP, Pasta DJ et al (2004) Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol 171: 703–707; discussion 707–708PubMedCrossRefGoogle Scholar
  21. Iacono F, Giannella R, Somma P et al (2005) Histological alterations in cavernous tissue after radical prostatectomy. J Urol 173: 1673–1676PubMedCrossRefGoogle Scholar
  22. Italiano G, Petrelli L, Marin A et al (1993) Ultrastructural analysis of the cavernous and dorsal penile nerves in experimental diabetes. Int J Impot Res 5: 149–160PubMedGoogle Scholar
  23. Juenemann KP, Lue TF, Luo JA et al (1987) The effect of cigarette smoking on penile erection. J Urol 138: 438–441PubMedGoogle Scholar
  24. Kaiser FE, Viosca SP, Morley JE et al (1988) Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc 36: 511–519PubMedGoogle Scholar
  25. Leungwattanakij S, Bivalacqua TJ, Usta MF et al (2003) Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 24: 239–245PubMedGoogle Scholar
  26. Levine FJ, Greenfield AJ, Goldstein I (1990) Arteriographically determined occlusive disease within the hypogastric-cavernous bed in impotent patients following blunt perineal and pelvic trauma. J Urol 144: 1147–1153PubMedGoogle Scholar
  27. Lue TF (2000) Erectile dysfunction. N Engl J Med 342: 1802–1813PubMedCrossRefGoogle Scholar
  28. Maatman TJ, Montague DK, Martin LM (1987) Erectile dysfunction in men with diabetes mellitus. Urology 29: 589–592PubMedCrossRefGoogle Scholar
  29. Miller NS, Gold MS (1988) The human sexual response and alcohol and drugs. J Subst Abuse Treat 5: 171–177PubMedCrossRefGoogle Scholar
  30. Morano S (2003) Pathophysiology of diabetic sexual dysfunction. J Endocrinol Invest 26: 65–69PubMedGoogle Scholar
  31. Mulhall JP, Slovick R, Hotaling J et al (2002) Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 167: 1371–1375PubMedCrossRefGoogle Scholar
  32. Murray FT, Johnson RD, Sciadini M et al (1992) Erectile and copulatory dysfunction in chronically diabetic BB/WOR rats. Am J Physiol 263: E151–157PubMedGoogle Scholar
  33. Murray FT, Wyss HU, Thomas RG et al (1987) Gonadal dysfunction in diabetic men with organic impotence. J Clin Endocrinol Metab 65: 127–135PubMedCrossRefGoogle Scholar
  34. Nakanishi S, Yamane K, Kamei N et al (2004) Erectile dysfunction is strongly linked with decreased libido in diabetic men. Aging Male 7: 113–119PubMedCrossRefGoogle Scholar
  35. Nicolosi A, Laumann EO, Glasser DB et al (2004) Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology 64:991–997PubMedCrossRefGoogle Scholar
  36. Papatsoris AG, Korantzopoulos PG (2006) Hypertension, antihypertensive therapy, and erectile dysfunction. Angiology 57: 47–52PubMedCrossRefGoogle Scholar
  37. Rajfer J, Rosciszewski A, Mehringer M (1988) Prevalence of corporeal venous leakage in impotent men. J Urol 140: 69–71PubMedGoogle Scholar
  38. Rosen MP, Greenfield AJ, Walker TG et al (1991) Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J Urol 145: 759–763PubMedGoogle Scholar
  39. Rosen R, Altwein J, Boyle P et al (2003) Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44: 637–649PubMedCrossRefGoogle Scholar
  40. Rowland DL, Greenleaf W, Mas M et al (1989) Penile and finger sensory thresholds in young, aging, and diabetic males. Arch Sex Behav 18: 1–12PubMedCrossRefGoogle Scholar
  41. Saenz de Tejada I, Goldstein I, Azadzoi K et al (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320: 1025–1030PubMedCrossRefGoogle Scholar
  42. Seftel AD, Vaziri ND, Ni Z et al (1997) Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 50: 1016–1026PubMedCrossRefGoogle Scholar
  43. Shabsigh R, Klein LT, Seidman S et al (1998) Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 52: 848–852PubMedCrossRefGoogle Scholar
  44. Shiri R, Koskimaki J, Hakkinen J et al (2006) Cardiovascular drug use and the incidence of erectile dysfunction. Int J Impot Res 19:208–212PubMedCrossRefGoogle Scholar
  45. Sun P, Cameron A, Seftel A et al (2006) Erectile dysfunction-an observable marker of diabetes mellitus? A large national epidemiological study. J Urol 176: 1081–1085; discussion 1085PubMedCrossRefGoogle Scholar
  46. Vernet D, Cai L, Garban H et al (1995) Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 136: 5709–5717PubMedCrossRefGoogle Scholar
  47. Walsh PC, Donker PJ (1982) Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128: 492–497PubMedGoogle Scholar
  48. Wang CJ, Shen SY, Wu CC et al (1993) Penile blood flow study in diabetic impotence. Urol Int 50: 209–212PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Anthony J. Bella
    • 1
  • William O. Brant
    • 2
  • Tom F. Lue
    • 3
  1. 1.Department of Surgery and Associate Scientist (Neuroscience)University of Ottawa, The Ottawa HospitalOttawaCanada
  2. 2.VailUSA
  3. 3.San FranciscoUSA

Personalised recommendations